---
title: Altering phosphorylation of dystrophin S3059 to attenuate cancer cachexia
date: '2024-12-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39740759/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250101170753&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'AIMS: Cancer cachexia affects up to 80 % of patients with advanced cancer
  and accounts for >20 % of all cancer-related deaths. Sarcolemmal localization of
  dystrophin, a key protein within the dystrophin-glycoprotein complex (DGC), is perturbed
  in multiple muscle wasting conditions, including cancer cachexia, indicating a potential
  role for dystrophin in the maintenance of muscle mass. Strategies to preserve dystrophin
  expression at the sarcolemma might therefore combat muscle ...'
disable_comments: true
---
AIMS: Cancer cachexia affects up to 80 % of patients with advanced cancer and accounts for >20 % of all cancer-related deaths. Sarcolemmal localization of dystrophin, a key protein within the dystrophin-glycoprotein complex (DGC), is perturbed in multiple muscle wasting conditions, including cancer cachexia, indicating a potential role for dystrophin in the maintenance of muscle mass. Strategies to preserve dystrophin expression at the sarcolemma might therefore combat muscle ...